miR-196b regulates gastric cancer cell proliferation and invasion via PI3K/AKT/mTOR signaling pathway

Li,Na; Wang,Weiqiang; Xu,Bin; Gong,Hongyun

doi:10.3892/ol.2016.4141

miR-196b regulates gastric cancer cell proliferation and invasion via PI3K/AKT/mTOR signaling pathway

Authors:
- Na Li
- Weiqiang Wang
- Bin Xu
- Hongyun Gong
View Affiliations

Affiliations: Department of Oncology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China, Department of Gastroenterology, 281st Hospital of the PLA, Qinhuangdao, Hebei 066100, P.R. China
Published online on: January 26, 2016 https://doi.org/10.3892/ol.2016.4141
Pages: 1745-1749
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

miR-196b plays a significant role in the regulation of tumor pathogenesis and progression by promoting tumor cell proliferation, invasion and metastasis. In order to explore the effects of miR‑196b on the proliferation and invasion ability of gastric cancer cells and the involved mechanisms, in the present study the lentivirus expression vector miR‑196b was constructed and transfected into the human gastric cancer cell line MKN28. The cell proliferation and invasion ability were observed and the expression of PI3K/AKT/mTOR protein and mRNA were analyzed following upregulation of the expression of miR‑196b. 3‑(4,5‑dimethylthiazol‑2‑yl)‑2,5‑diphenyltetrazolium bromide (MTT) results revealed that the proliferation of MKN28 cells was notably increased following upregulation of the expression of miR‑196b (P<0.01). Flow cytometry analysis demonstrated that miR‑196b decreased the ratios of cells in the GO/G1 stage but increased the ratios in S and G2 stage (P<0.05). Furthermore, the cell clone formation and trans‑membrane rates were increased following upregulation of the expression of miR‑196b (P<0.01). The nude mouse tumor growth test revealed that tumor growth was more rapid following upregulation of the expression of miR‑196b. The expression of PI3K/AKT/mTOR protein and mRNA were increased following upregulation of the expression of miR‑196b. We concluded that upregulation of miR‑196b promotes the proliferation and invasion ability of gastric cancer cells by regulating the PI3K/AKT/mTOR pathway.

View Figures

View References

1	Wu R, Li F, Zhu J, Tang R, Qi Q, Zhou X, Li R, Wang W, Hua D and Chen W: A functional variant at mir-132-3p, mir-212-3p and mir-361-5p binding site in cd80 gene alters susceptibility to gastric cancer in a Chinese Han population. Med Oncol. 31:602014. View Article : Google Scholar : PubMed/NCBI
2	Xu YJ and Fan Y: Mir-215/192 participates in gastric cancer progression. Clin Transl Oncol. 17:34–40. 2015. View Article : Google Scholar : PubMed/NCBI
3	Shen ZY, Zhang ZZ, Liu H, Zhao EH and Cao H: Mir-375 inhibits the proliferation of gastric cancer cells by repressing ERBB2 expression. Exp Ther Med. 7:1757–1761. 2014.PubMed/NCBI
4	Li H, Xie S, Liu M, Chen Z, Liu X, Wang L, Li D and Zhou Y: The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis. Int J Oncol. 45:197–208. 2014.PubMed/NCBI
5	Xia J, Guo X, Yan J and Deng K: The role of mir-148a in gastric cancer. J Cancer Res Clin Oncol. 140:1451–1456. 2014. View Article : Google Scholar : PubMed/NCBI
6	Zheng Y, Li S, Ding Y, Wang Q, Luo H, Shi Q, Hao Z, Xiao G and Tong S: The role of mir-18a in gastric cancer angiogenesis. Hepatogastroenterology. 60:1809–1813. 2013.PubMed/NCBI
7	Duan Y, Hu L, Liu B, Yu B, Li J, Yan M, Yu Y, Li C, Su L, Zhu Z, et al: Tumor suppressor miR-24 restrains gastric cancer progression by downregulating regIV. Mol Cancer. 13:1272014. View Article : Google Scholar : PubMed/NCBI
8	He XJ, Ma YY, Yu S, Jiang XT, Lu YD, Tao L, Wang HP, Hu ZM and Tao HQ: Up-regulated miR-199a-5p in gastric cancer functions as an oncogene and targets klotho. BMC Cancer. 14:2182014. View Article : Google Scholar : PubMed/NCBI
9	Hornstein E, Mansfield JH, Yekta S, Hu JK, Harfe BD, McManus MT, Baskerville S, Bartel DP and Tabin CJ: The microRNA-miR-196 acts upstream of hoxb8 and shh in limb development. Nature. 438:671–674. 2005. View Article : Google Scholar : PubMed/NCBI
10	Sehm T, Sachse C, Frenzel C and Echeverri K: miR-196 is an essential early-stage regulator of tail regeneration, upstream of key spinal cord patterning events. Dev Biol. 334:468–480. 2009. View Article : Google Scholar : PubMed/NCBI
11	Kawasaki H and Taira K: MicroRNA-196 inhibits HOXB8 expression in myeloid differentiation of HL60 cells. Nucleic Acids Symp Ser (Oxf). 48:211–212. 2004. View Article : Google Scholar : PubMed/NCBI
12	Brest P, Lapaquette P, Souidi M, Lebrigand K, Cesaro A, Vouret-Craviari V, Mari B, Barbry P, Mosnier JF, Hébuterne X, et al: A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in crohn's disease. Nat Genet. 43:242–245. 2011. View Article : Google Scholar : PubMed/NCBI
13	Hezova R, Kovarikova A, Bienertova-Vasku J, Sachlova M, Redova M, Vasku A, Svoboda M, Radova L, Kiss I, Vyzula R and Slaby O: Evaluation of SNPs in miR-196-a2, miR-27a and miR-146a as risk factors of colorectal cancer. World J Gastroenterol. 18:2827–2831. 2012. View Article : Google Scholar : PubMed/NCBI
14	Hou W, Tian Q, Zheng J and Bonkovsky HL: MicroRNA-196 represses Bach1 protein and hepatitis C virus gene expression in human hepatoma cells expressing hepatitis C viral proteins. Hepatology. 51:1494–1504. 2010. View Article : Google Scholar : PubMed/NCBI
15	Chen C, Zhang Y, Zhang L, Weakley SM and Yao Q: MicroRNA-196: Critical roles and clinical applications in development and cancer. J Cell Mol Med. 15:14–23. 2011. View Article : Google Scholar : PubMed/NCBI
16	Popovic R, Riesbeck LE, Velu CS, Chaubey A, Zhang J, Achille NJ, Erfurth FE, Eaton K, Lu J, Grimes HL, et al: Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization. Blood. 113:3314–3322. 2009. View Article : Google Scholar : PubMed/NCBI
17	Schotte D, Lange-Turenhout EA, Stumpel DJ, Stam RW, Buijs-Gladdines JG, Meijerink JP, Pieters R and Den Boer ML: Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia. Haematologica. 95:1675–1682. 2010. View Article : Google Scholar : PubMed/NCBI
18	Li Z, Huang H, Chen P, He M, Li Y, Arnovitz S, Jiang X, He C, Hyjek E, Zhang J, et al: miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia. Nat Commun. 3:6882012. View Article : Google Scholar : PubMed/NCBI
19	Abbud-Antaki RA, Marhefka JN, DeLuca AL and Zuromskis MP: The cancer biochip system: a functional genomic assay for anchorage-independent three-dimensional breast cancer cell growth. Horm Cancer. 3:261–270. 2012. View Article : Google Scholar : PubMed/NCBI
20	Guadamillas MC, Cerezo A and Del Pozo MA: Overcoming anoikis-pathways to anchorage-independent growth in cancer. J Cell Sci. 124:3189–3197. 2011. View Article : Google Scholar : PubMed/NCBI
21	Okabe H, Ishimoto T, Mima K, Nakagawa S, Hayashi H, Kuroki H, Imai K, Nitta H, Saito S, Hashimoto D, et al: CD44s signals the acquisition of the mesenchymal phenotype required for anchorage-independent cell survival in hepatocellular carcinoma. Br J Cancer. 110:958–966. 2014. View Article : Google Scholar : PubMed/NCBI
22	Marshall J: Transwell(®) invasion assays. Methods Mol Biol. 769:97–110. 2011. View Article : Google Scholar : PubMed/NCBI
23	Tapia O, Riquelme I, Leal P, Sandoval A, Aedo S, Weber H, Letelier P, Bellolio E, Villaseca M, Garcia P and Roa JC: The Pi3K/AKT/mTOR pathway is activated in gastric cancer with potential prognostic and predictive significance. Virchows Arch. 465:25–33. 2014. View Article : Google Scholar : PubMed/NCBI
24	Sukawa Y, Yamamoto H, Nosho K, Ito M, Igarashi H, Naito T, Mitsuhashi K, Matsunaga Y, Takahashi T, Mikami M, et al: HER2 expression and Pi3K-Akt pathway alterations in gastric cancer. Digestion. 89:12–17. 2014. View Article : Google Scholar : PubMed/NCBI
25	Xie X, Tang B, Zhou J, Gao Q and Zhang P: Inhibition of the Pi3K/Akt pathway increases the chemosensitivity of gastric cancer to vincristine. Oncol Rep. 30:773–782. 2013.PubMed/NCBI
26	Ye B, Jiang LL, Xu HT, Zhou DW and Li ZS: Expression of Pi3K/AKT pathway in gastric cancer and its blockade suppresses tumor growth and metastasis. Int J Immunopathol Pharmacol. 25:627–636. 2012.PubMed/NCBI